Barclays Upgrades Allergen (AGN) to Equalweight, Following Takeover Bid
Tweet Send to a Friend
Barclays analyst Balaji Prasad upgraded Allergen (NYSE: AGN) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
